— Know what they know.
Not Investment Advice

CRL NYSE

Charles River Laboratories International, Inc.
1W: -0.2% 1M: -14.1% 3M: -6.0% YTD: -21.5% 1Y: +10.7% 3Y: -15.6% 5Y: -51.7%
$160.30
+1.44 (+0.91%)
 
Weekly Expected Move ±8.0%
$127 $139 $151 $163 $175
NYSE · Healthcare · Medical - Diagnostics & Research · Alpha Radar Strong Sell · Power 33 · $7.7B mcap · 48M float · 1.91% daily turnover · Short 71% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
38.2 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 6.2%  ·  5Y Avg: 6.6%
Cost Advantage
52
Intangibles
14
Switching Cost
34
Network Effect
40
Scale ★
65
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CRL has No discernible competitive edge (38.2/100). The business operates without significant structural advantages. The primary source of advantage is Efficient Scale. ROIC of 6.2% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$192
Low
$211
Avg Target
$220
High
Based on 4 analysts since May 7, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 24Hold: 11Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$211.67
Analysts6
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-08 Robert W. Baird Eric Coldwell $193 $213 +20 +21.3% $175.56
2026-05-08 Evercore ISI $260 $220 -40 +24.8% $176.32
2026-05-08 Mizuho Securities $175 $192 +17 +5.7% $181.68
2026-05-08 Barclays Luke Sergott $210 $220 +10 +21.1% $181.68
2026-04-14 Barclays Luke Sergott $200 $210 +10 +17.8% $178.34
2026-04-13 RBC Capital Initiated $215 +20.6% $178.34
2026-02-20 Mizuho Securities $215 $175 -40 +6.6% $164.24
2026-02-19 Robert W. Baird Eric Coldwell $231 $193 -38 +22.0% $158.18
2026-02-19 Barclays Luke Sergott $215 $200 -15 +26.6% $158.00
2026-01-13 Robert W. Baird $224 $231 +7 +4.2% $221.69
2026-01-13 Evercore ISI $200 $260 +60 +15.5% $225.11
2026-01-09 Robert W. Baird Eric Coldwell $239 $224 -15 +2.1% $219.49
2026-01-09 Mizuho Securities Ann Hynes $200 $215 +15 -0.2% $215.51
2025-12-18 Mizuho Securities $174 $200 +26 +2.1% $195.98
2025-12-15 Barclays $195 $215 +20 +11.4% $192.97
2025-12-01 Morgan Stanley Kallum Titchmarsh Initiated $185 +5.1% $176.09
2025-11-17 Argus Research $440 $200 -240 +20.0% $166.73
2025-10-17 Mizuho Securities Ann Hynes $210 $174 -36 -0.5% $174.95
2025-10-03 Evercore ISI Elizabeth Anderson $265 $200 -65 +10.4% $181.18
2025-10-02 Barclays Luke Sergott $205 $195 -10 +14.4% $170.48
2025-09-09 Jefferies $280 $195 -85 +23.9% $157.38
2024-10-15 Barclays Luke Sergott $230 $205 -25 +6.1% $193.14
2024-10-14 Redburn Partners Jamie Clark Initiated $151 -21.7% $192.97
2024-09-17 Mizuho Securities Ann Hynes Initiated $210 +1.7% $206.44
2024-08-08 Deutsche Bank Justin Bowers Initiated $240 +19.8% $200.34
2024-07-10 Robert W. Baird Eric Coldwell Initiated $239 +18.4% $201.85
2024-06-27 Barclays Luke Sergott Initiated $230 +10.9% $207.35
2024-06-06 Goldman Sachs Matthew Sykes Initiated $290 +34.2% $216.12
2024-05-09 Evercore ISI Elizabeth Anderson $300 $265 -35 +15.2% $230.09
2024-04-01 Evercore ISI Elizabeth Anderson Initiated $300 +10.7% $270.95
2022-05-05 KeyBanc Donald Hooker Initiated $300 +16.5% $257.51
2022-04-25 Wells Fargo Initiated $325 +26.1% $257.75
2022-04-25 Jefferies David Windley $464 $280 -184 +2.6% $273.03
2022-01-10 Jefferies David Windley Initiated $464 +29.6% $357.95
2021-11-23 Argus Research David Toung Initiated $440 +16.6% $377.51
2021-08-16 Cowen & Co. Daniel Brennan Initiated $465 +11.4% $417.45
2021-08-03 Credit Suisse Katie Tryhane Initiated $385 -7.5% $416.31
2021-05-27 J.P. Morgan Tycho Peterson Initiated $390 +15.4% $337.99
2021-05-24 Guggenheim Sandy Draper Initiated $369 +12.0% $329.52

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
3
ROE
1
ROA
1
D/E
1
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CRL receives an overall rating of C. Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-07 C- C
2026-02-18 C C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

28 Grade D
Profitability
16
Balance Sheet
45
Earnings Quality
43
Growth
33
Value
30
Momentum
35
Safety
50
Cash Flow
32
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CRL scores highest in Safety (50/100) and lowest in Profitability (16/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.29
Grey Zone
Piotroski F-Score
4/9
Beneish M-Score
-2.96
Unlikely Manipulator
Ohlson O-Score
-6.81
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BBB-
Score: 54.6/100
Trend: Improving
Earnings Quality
OCF/NI: -3.29x
Accruals: -10.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CRL scores 2.29, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CRL scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CRL's score of -2.96 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CRL's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CRL receives an estimated rating of BBB- (score: 54.6/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-42.50x
PEG
0.42x
P/S
1.92x
P/B
2.67x
P/FCF
19.91x
P/OCF
12.83x
EV/EBITDA
13.23x
EV/Revenue
2.64x
EV/EBIT
23.44x
EV/FCF
27.20x
Earnings Yield
-2.37%
FCF Yield
5.02%
Shareholder Yield
2.77%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CRL currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.116
NI / EBT
×
Interest Burden
-0.364
EBT / EBIT
×
EBIT Margin
0.113
EBIT / Rev
×
Asset Turnover
0.549
Rev / Assets
×
Equity Multiplier
2.213
Assets / Equity
=
ROE
-5.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CRL's ROE of -5.6% is driven by Asset Turnover (0.549), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.12 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$160.30
Median 1Y
$149.42
5th Pctile
$73.41
95th Pctile
$306.63
Ann. Volatility
42.0%
Analyst Target
$211.67
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
James C. Foster
Chair, President, Chief Executive Officer and Director
$1,461,866 $9,138,724 $14,096,924
Birgit Girshick Corporate
Executive Vice President, Chief Operating Officer
$704,811 $2,964,471 $4,989,672
Flavia H. Pease
Corporate Executive Vice President, Chief Financial Officer
$621,915 $1,722,601 $3,811,326
Joseph LaPlume Corporate
Executive Vice President Corporate Development and Strategy
$539,000 $1,702,429 $3,058,456
William D. Barbo
Corporate Executive Vice President
$568,144 $1,522,274 $2,908,735

CEO Pay Ratio

374:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $14,096,924
Avg Employee Cost (SGA/emp): $37,719
Employees: 19,700

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
19,700
-2.0% YoY
Revenue / Employee
$203,826
Rev: $4,015,382,000
Profit / Employee
$-7,327
NI: $-144,338,000
SGA / Employee
$37,719
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 21.1% 21.2% 16.8% 18.2% 19.1% 18.8% 17.6% 18.0% 17.6% 17.2% 14.4% 13.4% 13.1% 12.6% 0.3% -0.9% -2.0% -2.4% -4.4% -5.6% -5.57%
ROA 7.8% 7.8% 6.2% 6.8% 7.1% 7.0% 6.6% 6.8% 6.6% 6.5% 6.0% 5.6% 5.5% 5.2% 0.1% -0.4% -0.9% -1.1% -2.0% -2.5% -2.52%
ROIC 10.3% 11.1% 8.9% 9.2% 10.1% 9.8% 8.8% 8.9% 8.7% 8.6% 8.0% 7.4% 7.3% 6.8% 1.0% -2.3% 1.6% 1.9% 5.6% 6.2% 6.22%
ROCE 12.9% 12.6% 9.3% 9.7% 9.7% 9.6% 10.5% 11.2% 11.4% 11.6% 10.1% 9.6% 9.5% 9.1% 3.4% 2.3% 1.5% 1.4% 6.6% 7.5% 7.55%
Gross Margin 37.4% 37.6% 38.4% 36.9% 36.7% 37.4% 36.3% 36.7% 37.6% 35.2% 35.9% 34.1% 34.5% 34.6% 28.4% 32.3% 34.6% 33.7% 31.0% 28.0% 28.05%
Operating Margin 15.0% 17.4% 19.1% 16.3% 19.3% 15.3% 14.9% 16.3% 15.6% 14.8% 13.1% 12.5% 14.8% 11.6% -16.7% 7.6% 9.7% 13.3% 12.1% 12.0% 12.04%
Net Margin 9.7% 11.5% 15.2% 10.2% 11.2% 9.8% 17.0% 10.0% 9.2% 8.5% 18.5% 6.7% 8.8% 6.8% -21.5% 2.6% 5.1% 5.4% -27.8% -1.5% -1.49%
EBITDA Margin 23.2% 23.3% 26.8% 21.4% 23.0% 21.1% 32.5% 23.6% 22.8% 22.0% 31.8% 21.7% 23.2% 20.8% -8.6% 18.7% 21.4% 19.7% 20.0% 18.8% 18.78%
FCF Margin 14.8% 13.2% 15.0% 11.4% 9.2% 7.4% 7.4% 6.7% 6.9% 8.7% 8.8% 10.1% 11.9% 13.8% 12.4% 14.0% 14.4% 13.5% 12.9% 9.7% 9.72%
OCF Margin 20.5% 19.6% 21.5% 19.1% 17.8% 16.2% 15.6% 15.3% 15.0% 16.6% 16.6% 17.1% 18.4% 19.6% 18.1% 19.3% 19.5% 18.6% 18.4% 15.1% 15.07%
ROE 3Y Avg snapshot only 1.82%
ROE 5Y Avg snapshot only 7.76%
ROA 3Y Avg snapshot only 0.78%
ROIC 3Y Avg snapshot only 4.02%
ROIC Economic snapshot only 6.09%
Cash ROA snapshot only 8.51%
Cash ROIC snapshot only 10.09%
CROIC snapshot only 6.50%
NOPAT Margin snapshot only 9.30%
Pretax Margin snapshot only -4.11%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 17.78%
SBC / Revenue snapshot only 1.56%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 47.68 59.58 49.68 33.91 26.18 22.04 23.02 20.91 22.36 21.29 25.71 32.01 24.80 24.76 916.78 -250.62 -106.87 -87.96 -69.44 -42.19 -42.496
P/S Ratio 5.77 6.90 5.49 3.95 3.15 2.54 2.82 2.54 2.59 2.40 2.96 3.42 2.63 2.52 2.33 1.97 1.84 1.82 2.50 1.93 1.917
P/B Ratio 8.93 11.17 7.66 5.65 4.58 3.79 3.76 3.49 3.64 3.40 3.39 3.91 2.98 2.84 2.73 2.29 2.14 2.12 3.17 2.46 2.668
P/FCF 39.02 52.27 36.51 34.77 34.29 34.39 37.96 37.71 37.40 27.45 33.40 33.96 22.00 18.25 18.82 14.04 12.79 13.51 19.33 19.91 19.911
P/OCF 28.08 35.27 25.53 20.66 17.69 15.66 18.07 16.57 17.31 14.50 17.84 19.94 14.28 12.85 12.85 10.19 9.39 9.80 13.59 12.83 12.835
EV/EBITDA 24.50 30.28 27.29 20.14 16.73 14.43 14.26 12.82 13.03 12.17 14.53 16.69 13.42 13.15 20.60 19.12 18.79 19.12 16.07 13.23 13.234
EV/Revenue 6.36 7.46 6.32 4.76 3.95 3.33 3.54 3.24 3.28 3.08 3.63 4.09 3.31 3.21 2.96 2.60 2.46 2.45 3.21 2.64 2.643
EV/EBIT 34.73 43.69 40.36 29.86 24.98 21.77 20.61 18.20 18.41 17.18 20.88 24.52 19.99 20.02 54.55 69.95 101.08 110.56 32.34 23.44 23.437
EV/FCF 43.01 56.54 42.07 41.95 43.04 44.97 47.67 48.11 47.29 35.22 41.04 40.71 27.73 23.23 23.86 18.53 17.16 18.16 24.83 27.20 27.199
Earnings Yield 2.1% 1.7% 2.0% 2.9% 3.8% 4.5% 4.3% 4.8% 4.5% 4.7% 3.9% 3.1% 4.0% 4.0% 0.1% -0.4% -0.9% -1.1% -1.4% -2.4% -2.37%
FCF Yield 2.6% 1.9% 2.7% 2.9% 2.9% 2.9% 2.6% 2.7% 2.7% 3.6% 3.0% 2.9% 4.5% 5.5% 5.3% 7.1% 7.8% 7.4% 5.2% 5.0% 5.02%
PEG Ratio snapshot only 0.423
Price/Tangible Book snapshot only 129.029
EV/OCF snapshot only 17.533
EV/Gross Profit snapshot only 8.295
Acquirers Multiple snapshot only 22.451
Shareholder Yield snapshot only 2.77%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.43 1.43 1.23 1.23 1.23 1.23 1.32 1.32 1.32 1.32 1.52 1.52 1.52 1.52 1.41 1.41 1.41 1.41 1.29 1.29 1.292
Quick Ratio 1.21 1.21 1.04 1.04 1.04 1.04 1.08 1.08 1.08 1.08 1.16 1.16 1.16 1.16 1.13 1.13 1.13 1.13 1.02 1.02 1.025
Debt/Equity 1.02 1.02 1.26 1.26 1.26 1.26 1.04 1.04 1.04 1.04 0.85 0.85 0.85 0.85 0.79 0.79 0.79 0.79 0.97 0.97 0.969
Net Debt/Equity 0.91 0.91 1.17 1.17 1.17 1.17 0.96 0.96 0.96 0.96 0.78 0.78 0.78 0.78 0.73 0.73 0.73 0.73 0.90 0.90 0.901
Debt/Assets 0.39 0.39 0.46 0.46 0.46 0.46 0.41 0.41 0.41 0.41 0.37 0.37 0.37 0.37 0.36 0.36 0.36 0.36 0.43 0.43 0.430
Debt/EBITDA 2.54 2.56 3.91 3.74 3.68 3.68 3.14 3.00 2.95 2.90 2.97 3.04 3.05 3.10 4.69 4.99 5.16 5.27 3.83 3.81 3.812
Net Debt/EBITDA 2.27 2.29 3.61 3.45 3.40 3.40 2.90 2.77 2.73 2.68 2.70 2.76 2.77 2.82 4.35 4.63 4.79 4.90 3.56 3.55 3.546
Interest Coverage 6.12 6.13 7.50 10.79 14.17 16.02 11.51 8.64 6.43 5.48 5.25 5.00 5.00 4.94 1.74 1.25 0.84 0.80 3.72 4.29 4.289
Equity Multiplier 2.60 2.60 2.77 2.77 2.77 2.77 2.55 2.55 2.55 2.55 2.28 2.28 2.28 2.28 2.17 2.17 2.17 2.17 2.25 2.25 2.255
Cash Ratio snapshot only 0.191
Debt Service Coverage snapshot only 7.595
Cash to Debt snapshot only 0.070
FCF to Debt snapshot only 0.128
Defensive Interval snapshot only 416.3 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.64 0.67 0.57 0.58 0.59 0.60 0.54 0.56 0.57 0.58 0.52 0.52 0.52 0.51 0.52 0.51 0.51 0.51 0.55 0.55 0.549
Inventory Turnover 11.74 12.35 11.46 11.78 12.01 12.32 11.05 11.38 11.57 11.77 8.26 8.31 8.34 8.33 8.25 8.25 8.26 8.28 9.33 9.50 9.501
Receivables Turnover 5.78 6.05 5.62 5.76 5.85 6.00 6.68 6.87 7.02 7.08 7.50 7.47 7.41 7.38 7.63 7.58 7.59 7.58 6.59 6.61 6.611
Payables Turnover 17.39 18.28 13.76 14.14 14.41 14.79 12.44 12.81 13.03 13.26 14.02 14.10 14.16 14.13 17.58 17.58 17.59 17.63 18.63 18.98 18.981
DSO 63 60 65 63 62 61 55 53 52 52 49 49 49 49 48 48 48 48 55 55 55.2 days
DIO 31 30 32 31 30 30 33 32 32 31 44 44 44 44 44 44 44 44 39 38 38.4 days
DPO 21 20 27 26 25 25 29 28 28 28 26 26 26 26 21 21 21 21 20 19 19.2 days
Cash Conversion Cycle 73 70 70 69 67 66 58 57 56 55 67 67 67 67 71 72 72 72 75 74 74.4 days
Fixed Asset Turnover snapshot only 1.997
Operating Cycle snapshot only 93.6 days
Cash Velocity snapshot only 18.838
Capital Intensity snapshot only 1.772
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 19.1% 21.3% 21.1% 19.3% 12.7% 10.4% 12.3% 12.7% 13.3% 11.5% 3.9% 0.5% -2.4% -3.7% -1.9% -2.2% -1.2% -0.9% -0.9% 0.1% 0.11%
Net Income 46.0% 31.6% 7.3% 12.6% 11.9% 10.0% 24.4% 17.5% 9.2% 8.8% -2.4% -11.6% -10.8% -13.0% -97.8% -1.1% -1.2% -1.2% -15.0% -4.9% -4.85%
EPS 42.9% 29.4% 6.2% 12.1% 12.0% 10.6% 24.8% 17.2% 8.8% 8.2% -2.9% -12.3% -11.4% -13.0% -97.8% -1.1% -1.2% -1.2% -15.6% -5.1% -5.08%
FCF 16.4% 1.3% 40.0% -14.1% -30.1% -38.1% -44.6% -33.2% -14.5% 31.8% 23.9% 50.3% 68.3% 52.1% 37.3% 36.2% 18.8% -3.0% 3.4% -30.5% -30.53%
EBITDA 41.4% 23.5% 6.7% 7.5% 2.5% 3.2% 20.2% 20.4% 20.6% 22.4% 4.7% -2.3% -4.2% -7.1% -43.7% -45.9% -47.5% -47.9% 37.9% 47.3% 47.29%
Op. Income 40.3% 32.3% 36.3% 33.1% 27.1% 20.9% 10.4% 9.0% -2.6% -1.8% -5.2% -14.1% -13.2% -18.5% -63.2% -69.4% -77.8% -73.3% 88.6% 1.7% 1.69%
OCF Growth snapshot only -21.81%
Asset Growth snapshot only -5.22%
Equity Growth snapshot only -8.58%
Debt Growth snapshot only 12.54%
Shares Change snapshot only -3.74%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 17.4% 16.9% 16.0% 15.2% 14.6% 14.3% 14.9% 14.5% 15.0% 14.3% 12.2% 10.6% 7.6% 5.8% 4.6% 3.5% 3.0% 2.1% 0.3% -0.5% -0.53%
Revenue 5Y 17.0% 16.9% 16.1% 15.4% 15.3% 15.4% 16.4% 16.5% 15.6% 14.5% 12.8% 11.6% 10.7% 9.9% 9.1% 8.1% 7.9% 7.3% 6.5% 5.8% 5.77%
EPS 3Y 43.2% 40.5% 18.1% 21.2% 25.2% 22.3% 23.3% 24.9% 20.3% 15.7% 8.8% 4.9% 2.6% 1.4% -70.2%
EPS 5Y 21.2% 21.1% 18.8% 19.4% 17.9% 15.8% 29.4% 29.5% 29.0% 27.1% 14.9% 12.8% 13.6% 11.5% -47.5%
Net Income 3Y 45.4% 42.6% 20.0% 22.7% 26.5% 23.6% 24.5% 26.1% 21.3% 16.4% 9.2% 5.4% 2.9% 1.4% -70.2%
Net Income 5Y 22.8% 22.8% 20.4% 20.8% 19.3% 17.1% 31.6% 30.9% 30.3% 28.3% 16.0% 13.9% 14.6% 12.3% -47.2%
EBITDA 3Y 22.3% 20.4% 17.4% 18.1% 18.9% 19.2% 20.5% 22.0% 20.5% 16.0% 10.3% 8.1% 5.8% 5.5% -10.8% -14.0% -15.3% -16.0% -6.7% -8.0% -8.01%
EBITDA 5Y 20.4% 19.3% 16.8% 15.7% 14.9% 13.9% 16.6% 18.2% 17.7% 17.1% 15.3% 14.1% 14.2% 14.0% 0.6% -0.8% -2.5% -5.5% 0.8% 0.1% 0.15%
Gross Profit 3Y 18.7% 18.1% 16.7% 16.1% 15.6% 15.2% 15.1% 14.6% 15.9% 14.1% 11.9% 9.2% 4.7% 3.1% -0.1% -1.5% -1.7% -2.7% -3.3% -5.1% -5.15%
Gross Profit 5Y 16.0% 16.2% 15.6% 15.0% 14.7% 14.6% 15.8% 16.1% 15.8% 14.5% 12.3% 11.0% 9.8% 8.9% 6.8% 5.5% 5.7% 4.6% 4.2% 2.6% 2.58%
Op. Income 3Y 23.0% 23.2% 21.2% 22.6% 25.5% 24.2% 22.8% 21.3% 20.2% 16.2% 12.6% 7.6% 2.4% -1.1% -27.2% -34.1% -42.8% -40.2% -13.0% -10.9% -10.90%
Op. Income 5Y 19.2% 19.9% 20.0% 19.2% 18.9% 17.5% 17.7% 18.5% 18.1% 17.3% 13.2% 11.5% 10.8% 8.9% -8.3% -14.1% -19.7% -19.3% -0.2% 0.5% 0.51%
FCF 3Y 21.9% 11.6% 20.9% 15.5% 8.0% -1.8% -4.7% -10.6% -11.4% -6.2% -1.3% -4.8% 0.2% 7.4% -1.9% 11.0% 19.6% 24.8% 20.7% 12.4% 12.44%
FCF 5Y 14.4% 14.6% 17.0% 12.3% 6.4% 4.3% 4.8% 2.1% 1.6% 2.5% 3.9% 9.1% 12.6% 13.7% 8.1% 7.9% 6.8% 4.0% 6.4% -4.0% -3.98%
OCF 3Y 22.4% 16.4% 19.9% 20.5% 17.8% 11.7% 8.8% 5.4% 3.3% 5.8% 7.8% 2.8% 3.7% 5.9% -1.2% 3.8% 6.3% 6.9% 6.0% -1.0% -1.04%
OCF 5Y 17.1% 18.5% 20.6% 18.7% 15.7% 15.0% 14.4% 12.9% 11.2% 10.4% 9.2% 12.2% 13.3% 12.6% 8.8% 7.7% 6.8% 4.9% 6.2% -1.3% -1.30%
Assets 3Y 23.3% 23.3% 22.1% 22.1% 22.1% 22.1% 17.4% 17.4% 17.4% 17.4% 14.3% 14.3% 14.3% 14.3% 2.3% 2.3% 2.3% 2.3% -2.1% -2.1% -2.09%
Assets 5Y 21.6% 21.6% 21.0% 21.0% 21.0% 21.0% 21.0% 21.0% 21.0% 21.0% 16.3% 16.3% 16.3% 16.3% 9.9% 9.9% 9.9% 9.9% 5.4% 5.4% 5.38%
Equity 3Y 26.5% 26.5% 24.4% 24.4% 24.4% 24.4% 22.1% 22.1% 22.1% 22.1% 19.4% 19.4% 19.4% 19.4% 10.9% 10.9% 10.9% 10.9% 2.1% 2.1% 2.07%
Book Value 3Y 24.6% 24.6% 22.5% 22.9% 23.1% 23.1% 20.9% 20.9% 21.1% 21.4% 18.9% 18.8% 19.0% 19.4% 11.2% 11.3% 12.4% 12.3% 3.5% 3.8% 3.76%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.98 0.98 0.98 0.98 0.99 0.99 0.99 0.99 1.00 0.99 0.98 0.96 0.94 0.91 0.87 0.81 0.76 0.72 0.66 0.59 0.594
Earnings Stability 0.77 0.80 0.91 0.89 0.87 0.88 0.98 0.98 0.98 0.97 0.93 0.83 0.79 0.74 0.06 0.10 0.16 0.22 0.56 0.62 0.620
Margin Stability 0.96 0.97 0.98 0.98 0.97 0.98 0.98 0.99 0.98 0.99 0.99 0.98 0.97 0.97 0.95 0.94 0.94 0.94 0.94 0.93 0.929
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.500
Earn. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.82 0.87 0.97 0.95 0.95 0.96 0.90 0.93 0.96 0.96 0.99 0.95 0.96 0.95 0.50 0.20 0.20 0.20 0.20 0.50 0.500
Earnings Smoothness 0.63 0.73 0.93 0.88 0.89 0.90 0.78 0.84 0.91 0.92 0.98 0.88 0.89 0.86 0.00
ROE Trend 0.02 0.01 -0.01 0.00 -0.00 -0.01 0.00 -0.01 -0.02 -0.02 -0.03 -0.04 -0.05 -0.05 -0.14 -0.15 -0.16 -0.16 -0.11 -0.11 -0.115
Gross Margin Trend 0.02 0.01 0.01 0.01 0.00 0.00 -0.00 -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -0.04 -0.04 -0.03 -0.03 -0.02 -0.02 -0.022
FCF Margin Trend 0.02 -0.01 0.02 -0.04 -0.06 -0.07 -0.07 -0.07 -0.05 -0.02 -0.02 0.01 0.04 0.06 0.04 0.06 0.05 0.02 0.02 -0.02 -0.023
Sustainable Growth Rate 21.1% 21.2% 16.8% 18.2% 19.1% 18.8% 17.6% 18.0% 17.6% 17.2% 14.4% 13.4% 13.1% 12.6% 0.3%
Internal Growth Rate 8.4% 8.4% 6.7% 7.2% 7.6% 7.5% 7.1% 7.3% 7.1% 6.9% 6.4% 5.9% 5.8% 5.5% 0.1%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.70 1.69 1.95 1.64 1.48 1.41 1.27 1.26 1.29 1.47 1.44 1.61 1.74 1.93 71.34 -24.60 -11.38 -8.98 -5.11 -3.29 -3.287
FCF/OCF 0.72 0.67 0.70 0.59 0.52 0.46 0.48 0.44 0.46 0.53 0.53 0.59 0.65 0.70 0.68 0.73 0.73 0.73 0.70 0.64 0.645
FCF/Net Income snapshot only -2.119
OCF/EBITDA snapshot only 0.755
CapEx/Revenue 5.8% 6.4% 6.5% 7.7% 8.6% 8.8% 8.2% 8.6% 8.0% 7.8% 7.7% 7.1% 6.4% 5.8% 5.8% 5.3% 5.2% 5.1% 5.5% 5.4% 5.36%
CapEx/Depreciation snapshot only 0.616
Accruals Ratio -0.05 -0.05 -0.06 -0.04 -0.03 -0.03 -0.02 -0.02 -0.02 -0.03 -0.03 -0.03 -0.04 -0.05 -0.09 -0.10 -0.11 -0.11 -0.12 -0.11 -0.108
Sloan Accruals snapshot only -0.059
Cash Flow Adequacy snapshot only 2.814
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 10.2% 10.2% 10.4% 9.2% 8.8% 8.9% 7.9% 4.8% 5.0% 5.1% 5.1% 3.3% 4.3% 28.9% 11.6%
Div. Increase Streak
Chowder Number
Buyback Yield 0.2% 0.2% 0.2% 0.3% 0.3% 0.4% 0.3% 0.2% 0.2% 0.2% 0.2% 0.1% 0.2% 1.2% 1.3% 5.9% 6.2% 4.9% 3.6% 2.8% 2.77%
Net Buyback Yield 0.2% 0.2% 0.2% 0.3% 0.3% 0.4% 0.3% 0.1% 0.1% 0.1% 0.1% 0.1% 0.2% 1.2% 1.3% 5.9% 6.2% 4.9% 3.6% 2.7% 2.75%
Total Shareholder Return 0.2% 0.2% 0.2% 0.3% 0.3% 0.4% 0.3% 0.1% 0.1% 0.1% 0.1% 0.1% 0.2% 1.2% 1.3% 5.9% 6.2% 4.9% 3.6% 2.7% 2.75%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.79 0.81 0.81 0.80 0.82 0.81 0.78 0.77 0.77 0.77 0.82 0.80 0.80 0.80 0.11 -1.05 3.81 3.76 1.45 1.12 1.116
Interest Burden (EBT/EBIT) 0.84 0.84 0.87 0.91 0.93 0.94 0.91 0.88 0.84 0.82 0.81 0.80 0.80 0.80 0.42 0.20 -0.18 -0.25 -0.25 -0.36 -0.364
EBIT Margin 0.18 0.17 0.16 0.16 0.16 0.15 0.17 0.18 0.18 0.18 0.17 0.17 0.17 0.16 0.05 0.04 0.02 0.02 0.10 0.11 0.113
Asset Turnover 0.64 0.67 0.57 0.58 0.59 0.60 0.54 0.56 0.57 0.58 0.52 0.52 0.52 0.51 0.52 0.51 0.51 0.51 0.55 0.55 0.549
Equity Multiplier 2.72 2.72 2.69 2.69 2.69 2.69 2.65 2.65 2.65 2.65 2.40 2.40 2.40 2.40 2.23 2.23 2.23 2.23 2.21 2.21 2.213
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $7.72 $7.69 $7.58 $8.23 $8.65 $8.51 $9.46 $9.65 $9.40 $9.20 $9.19 $8.46 $8.33 $8.01 $0.20 $-0.62 $-1.40 $-1.69 $-2.93 $-3.77 $-3.77
Book Value/Share $41.19 $41.01 $49.17 $49.39 $49.43 $49.43 $57.93 $57.87 $57.83 $57.67 $69.67 $69.38 $69.38 $69.73 $67.69 $68.07 $70.19 $70.03 $64.30 $64.65 $61.05
Tangible Book/Share $-9.39 $-9.35 $-24.02 $-24.13 $-24.15 $-24.15 $-16.13 $-16.12 $-16.11 $-16.06 $-7.02 $-6.99 $-6.99 $-7.02 $-2.12 $-2.13 $-2.20 $-2.20 $1.23 $1.23 $1.23
Revenue/Share $63.77 $66.45 $68.67 $70.72 $71.92 $73.73 $77.39 $79.56 $81.18 $81.69 $79.99 $79.31 $78.65 $78.73 $79.20 $79.10 $81.69 $81.41 $81.59 $82.27 $82.27
FCF/Share $9.43 $8.77 $10.32 $8.03 $6.60 $5.45 $5.74 $5.35 $5.62 $7.14 $7.08 $7.98 $9.39 $10.87 $9.81 $11.08 $11.73 $11.00 $10.54 $7.99 $7.99
OCF/Share $13.10 $12.99 $14.76 $13.51 $12.79 $11.98 $12.06 $12.18 $12.14 $13.52 $13.25 $13.59 $14.46 $15.43 $14.36 $15.27 $15.97 $15.16 $14.99 $12.40 $12.40
Cash/Share $4.47 $4.45 $4.78 $4.80 $4.80 $4.80 $4.55 $4.55 $4.54 $4.53 $5.36 $5.34 $5.34 $5.37 $3.81 $3.83 $3.95 $3.94 $4.34 $4.37 $3.92
EBITDA/Share $16.55 $16.37 $15.91 $16.72 $16.98 $16.99 $19.19 $20.09 $20.41 $20.67 $19.99 $19.46 $19.41 $19.20 $11.36 $10.74 $10.71 $10.45 $16.28 $16.43 $16.43
Debt/Share $42.08 $41.90 $62.18 $62.46 $62.51 $62.51 $60.29 $60.23 $60.18 $60.02 $59.40 $59.15 $59.14 $59.45 $53.27 $53.57 $55.24 $55.11 $62.29 $62.62 $62.62
Net Debt/Share $37.61 $37.45 $57.40 $57.66 $57.70 $57.70 $55.73 $55.68 $55.63 $55.48 $54.04 $53.81 $53.81 $54.08 $49.46 $49.74 $51.29 $51.18 $57.94 $58.26 $58.26
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 2.293
Altman Z-Prime snapshot only 3.447
Piotroski F-Score 7 6 6 5 5 5 8 7 8 7 5 5 5 6 5 4 5 4 5 4 4
Beneish M-Score -2.50 -2.45 -2.55 -2.47 -2.41 -2.46 -2.40 -2.42 -2.50 -2.43 -2.55 -2.55 -2.54 -2.66 -2.90 -3.06 -3.14 -3.07 -3.15 -2.96 -2.956
Ohlson O-Score snapshot only -6.813
ROIC (Greenblatt) snapshot only 19.38%
Net-Net WC snapshot only $-50.61
EVA snapshot only $-227137800.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB-
Credit Score 73.78 74.10 68.56 65.17 64.88 60.06 67.49 65.95 62.62 65.26 66.43 65.90 65.20 60.47 47.18 45.44 41.75 40.04 58.96 54.65 54.648
Credit Grade snapshot only 10
Credit Trend snapshot only 9.211
Implied Spread (bps) snapshot only 350.000
Industry Credit Rank snapshot only 51
Sector Credit Rank snapshot only 47

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms